N4 Pharma PLC (LON:N4P) shares rose 8.6% during mid-day trading on Monday . The stock traded as high as GBX 10.10 ($0.13) and last traded at GBX 10.10 ($0.13). Approximately 224,261 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 1,760,000 shares. The stock had previously closed at GBX 9.30 ($0.12).
ILLEGAL ACTIVITY NOTICE: “N4 Pharma (N4P) Stock Price Up 8.6%” was first reported by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://dakotafinancialnews.com/2019/01/14/n4-pharma-n4p-stock-price-up-8-6.html.
N4 Pharma Company Profile (LON:N4P)
N4 Pharma Plc, a specialist pharmaceutical company, develops and licenses novel therapeutic products pharmaceutical and biotechnology companies in the United Kingdom. It reformulates marketed generic drugs; and improves delivery of novel and existing vaccines and therapeutics. The company is developing Sildenafil for use in treating erectile dysfunction; Sartans for the treatment of hypertension; Aprepitant for use in oncology and pain relief; and Aprepitant for the treatment of premature ejaculation.
Recommended Story: How are institutional investors different from individual investors?
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.